Reddit: “Amyris and the Micro Drops – combining Metabolic Engineering and Screening”

I would like to deduce why the collaboration between Amyris and Biomillenia, announced on January 8, 2021, could be important.

Future synthetic biology is not about the lab scale development of a first strain, but more about advanced metabolic engineering leading to improved industrial scale strains able to produce the molecule in high yields in large-scale reactors, taking account of all possible parameters, promoters and switches.

The goal is a production strain with high process stability and performance metrics such as longer fermentation cycles, resistance to mutations, toxity and low susceptibility to stress (change in nutritions and conditions).

Contact Biomillenia

We are glad that you preferred to contact us. Please fill our short form and one of our friendly team members will contact you back.